Apatinib igecycline Hydrochloride inhibits survival of cancer cell

inhibits survival of cancer cell lines

SC-514 inhibits transcription of NF-κB-dependent genes in IL-1β-induced rheumatoid arthritis-derived synovial fibroblasts in a dose-dependent manner

respectively) inhibitor

is cell permeable

Apatinib igecycline Hydrochloride inhibits survival of cancer cellApatinib, also known as Rivoceranib, is an orally bioavailable, small molecule receptor tyrosine kinase inhibitor with potential antiangiogenic and antineoplastic activities. The free base form is also known as Rivoceranib. Apatinib selectively binds to and inhibits vascular endothelial growth factor receptor 2, which may inhibit VEGF stimulated endothelial cell migration and proliferation and decrease tumor microvessel density. In addition, this